Silence Therapeutics Plc American Depository Share (SLN) is a publicly traded Healthcare sector company. As of October 19, 2026, SLN trades at $19.58 with a market cap of $539.50M and a P/E ratio of -24.78. SLN moved +125.63% today. Year to date, SLN is +42.76%; over the trailing twelve months it is +31.71%. Its 52-week range spans $1.97 to $17.58. Analyst consensus is buy with an average price target of $37.00. Rallies surfaces SLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SLN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SLN recently traded at $19.58. Market cap is $539.50M. P/E ratio is -24.78. Revenue is $615.00K.
| Metric | Value |
|---|---|
| Price | $19.58 |
| Market Cap | $539.50M |
| P/E Ratio | -24.78 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.58 |
| 52-Week Low | $1.97 |
| Volume | 41.90M |
| Avg Volume | 0 |
| Revenue (TTM) | $615.00K |
| Net Income | $-59.95M |
| Gross Margin | 85.85% |
5 analysts cover SLN: 0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.00.